The Effect of Whole-Body Vibration Treatment Before Total Knee Arthroplasty

Sponsor
Gazi University (Other)
Overall Status
Not yet recruiting
CT.gov ID
NCT05967637
Collaborator
Gulhane Training and Research Hospital (Other)
24
2
14

Study Details

Study Description

Brief Summary

The study's objective is to investigate the effects of whole-body vibration therapy administered before surgery on various factors related to patients who undergo total knee arthroplasty. These factors include pain, swelling, skin temperature, normal joint movement, knee joint position sense, knee extensor muscle strength, functional status, and patient satisfaction.

Condition or Disease Intervention/Treatment Phase
  • Other: Whole body vibration
  • Other: Sham-Whole body vibration
N/A

Detailed Description

The study will include participants aged 50-80 who are planning to undergo total knee arthroplasty. According to the sample size analysis, a total of 40 people will be included in this study. The enrolled participants will be randomly assigned to one of two parallel groups: the whole-body vibration group or the sham whole-body vibration group. Both groups will receive standard patient education and exercise training.The experimental group will receive whole-body vibration along with exercise on the whole-body vibration device, while the control group (sham group) will receive sham vibration on the same device. All participants will receive treatment for a total of 5 days, one session per day.

Study Design

Study Type:
Interventional
Anticipated Enrollment :
24 participants
Allocation:
Randomized
Intervention Model:
Parallel Assignment
Masking:
Double (Participant, Outcomes Assessor)
Primary Purpose:
Treatment
Official Title:
The Effect of Whole-Body Vibration Treatment Before Total Knee Arthroplasty
Anticipated Study Start Date :
Aug 1, 2023
Anticipated Primary Completion Date :
Aug 1, 2024
Anticipated Study Completion Date :
Oct 1, 2024

Arms and Interventions

Arm Intervention/Treatment
Experimental: Whole-body vibration

Standard patient education and exercise training + whole body vibration

Other: Whole body vibration
The vibration will be applied for 10 minutes (30 seconds rest, 30 seconds training, 10 reps) in total with a low frequency (20 HZ) and low amplitude (2mm). Participants will be asked to stand in a squatting position by semi-flexing (30°) their knees during the 30-second vibration period.

Sham Comparator: Sham-whole-body vibration

Standard patient education and exercise training + sham whole body vibration

Other: Sham-Whole body vibration
The sham-whole body vibration treatment will follow the same procedures with the vibration machine off.

Outcome Measures

Primary Outcome Measures

  1. Baseline pain severity [baseline]

    The pain severity will be evaluated using an NRS rating from 0 to 10, with 0 representing no pain and 10 representing maximal pain.

  2. Change in pain severity from baseline to day 5 after interventions [up to 5 days after baseline]

    The pain severity will be evaluated using an NRS rating from 0 to 10, with 0 representing no pain and 10 representing maximal pain.pain and 10 representing maximal pain.

  3. Change in the preoperative pain severity on the 7th day of surgery [up to 7 days after surgery]

    The pain severity will be evaluated using an NRS rating from 0 to 10, with 0 representing no pain and 10 representing maximal pain.

  4. Change in pain severity from day 7 to day 14 post-surgery [up to 14 days after surgery]

    The pain severity will be evaluated using an NRS rating from 0 to 10, with 0 representing no pain and 10 representing maximal pain.

  5. Change in pain severity from day 14 to day 21 post-surgery [up to 21 days after surgery]

    The pain severity will be evaluated using an NRS rating from 0 to 10, with 0 representing no pain and 10 representing maximal pain.

  6. Baseline leg circumference [baseline]

    Knee swelling will be assessed by measuring the circumference of the mid-patella, thigh, and calf with the knee in full extension.

  7. Change in leg circumference from baseline to day 5 after interventions [up to 5 days after baseline]

    Knee swelling will be assessed by measuring the circumference of the mid-patella, thigh, and calf with the knee in full extension.

  8. Change in the preoperative leg circumference on the 7th day of surgery [up to 7 days after surgery]

    Knee swelling will be assessed by measuring the circumference of the mid-patella, thigh, and calf with the knee in full extension.

  9. Change in leg circumference from day 7 to day 14 post-surgery [up to 14 days after surgery]

    Knee swelling will be assessed by measuring the circumference of the mid-patella, thigh, and calf with the knee in full extension.

  10. Change in leg circumference from day 14 to day 21 post-surgery [up to 21 days after surgery]

    Knee swelling will be assessed by measuring the circumference of the mid-patella, thigh, and calf with the knee in full extension.

  11. Baseline range of motion [baseline]

    The knee flexion and extension ranges of motion will be measured using a goniometer in the supine position.

  12. Change in range of motion from baseline to day 5 after interventions [up to 5 days after baseline]

    The knee flexion and extension ranges of motion will be measured using a goniometer in the supine position.

  13. Change in the preoperative range of motion on the 7th day of surgery [up to 7 days after surgery]

    The knee flexion and extension ranges of motion will be measured using a goniometer in the supine position.

  14. Change in range of motion from day 7 to day 14 post-surgery [up to 14 days after surgery]

    The knee flexion and extension ranges of motion will be measured using a goniometer in the supine position.

  15. Change in range of motion from day 14 to day 21 post-surgery [up to 21 days after surgery]

    The knee flexion and extension ranges of motion will be measured using a goniometer in the supine position.

  16. Baseline muscle strength [baseline]

    Knee extensor muscle strength will be assessed using a hand-held dynamometer in the sitting position.

  17. Change in muscle strength from baseline to day 5 after interventions [up to 5 days after baseline]

    Knee extensor muscle strength will be assessed using a hand-held dynamometer in the sitting position.

  18. Change in the preoperative muscle strength on the 7th day of surgery [up to 7 days after surgery]

    Knee extensor muscle strength will be assessed using a hand-held dynamometer in the sitting position.

  19. Change in muscle strength from day 7 to day 14 post-surgery [up to 14 days after surgery]

    Knee extensor muscle strength will be assessed using a hand-held dynamometer in the sitting position.

  20. Change in muscle strength from day 14 to day 21 post-surgery [up to 21 days after surgery]

    Knee extensor muscle strength will be assessed using a hand-held dynamometer in the sitting position.

  21. Baseline skin temperature [baseline]

    A portable infrared thermometer will be used to measure knee skin temperature.

  22. Change in skin temperature from baseline to day 5 after interventions [up to 5 days after baseline]

    A portable infrared thermometer will be used to measure knee skin temperature.

  23. Change in the preoperative skin temperature on the 7th day of surgery [up to 7 days after surgery]

    A portable infrared thermometer will be used to measure knee skin temperature.

  24. Change in skin temperature from day 7 to day 14 post-surgery [up to 14 days after surgery]

    A portable infrared thermometer will be used to measure knee skin temperature.

  25. Change in skin temperature from day 14 to day 21 post-surgery [up to 21 days after surgery]

    A portable infrared thermometer will be used to measure knee skin temperature.

  26. Baseline knee proprioception [baseline]

    Active reposition test will be measured using a digital inclinometer device.

  27. Change in knee proprioception from baseline to day 5 after interventions [up to 5 days after baseline]

    Active reposition test will be measured using a digital inclinometer device.

  28. Change in the preoperative knee proprioception on the 7th day of surgery [up to 7 days after surgery]

    Active reposition test will be measured using a digital inclinometer device.

  29. Change in knee proprioception from day 7 to day 14 post-surgery [up to 14 days after surgery]

    Active reposition test will be measured using a digital inclinometer device.

  30. Change in knee proprioception from day 14 to day 21 post-surgery [up to 21 days after surgery]

    Active reposition test will be measured using a digital inclinometer device.

  31. Baseline Time Up and Go [baseline]

    functional performance test

  32. Change in Time Up and Go from baseline to day 5 after interventions [up to 5 days after baseline]

    functional performance test

  33. Change in the preoperative Time Up and Go on the 7th day of surgery [up to 7 days after surgery]

    functional performance test

  34. Change in Time Up and Go from day 7 to day 14 post-surgery [up to 14 days after surgery]

    functional performance test

  35. Change in Time Up and Go from day 14 to day 21 post-surgery [up to 21 days after surgery]

    functional performance test

Secondary Outcome Measures

  1. SF-36 [baseline]

    The 36-Item Short-Form Health Survey (SF-36) is a general scoring instrument used to provide a health profile comprised of eight scaled scores. Each scale is instantly turned into a 0-100 scale, allowing identification of the patient's physical and mental status. A higher score means a better result.

  2. Change in the preoperative SF-36 on the 21st day of surgery [up to 21 days after surgery]

    The 36-Item Short-Form Health Survey (SF-36) is a general scoring instrument used to provide a health profile comprised of eight scaled scores. Each scale is instantly turned into a 0-100 scale, allowing identification of the patient's physical and mental status. A higher score means a better result.

  3. WOMAC [before interventions, 21st day after surgery]

    The WOMAC (Western Ontario and McMaster Universities Osteoarthritis Index) is a disease-specific self-report multidimensional questionnaire that assesses pain, stiffness, and physical functional disability. A higher score means a better result.

  4. Change in the preoperative WOMAC on the 21st day of surgery [up to 21 days after surgery]

    The WOMAC (Western Ontario and McMaster Universities Osteoarthritis Index) is a disease-specific self-report multidimensional questionnaire that assesses pain, stiffness, and physical functional disability. A higher score means a better result.

  5. Global Rating of Change Scales (GROC) [up to 21st day after surgery]

    The GROC score, which has seven response options ranging from 'much worse' (a score of 0) to 'much better' (a score of six), will be used to determine the subject's perception of overall improvement.

Eligibility Criteria

Criteria

Ages Eligible for Study:
55 Years and Older
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
No
Inclusion Criteria:
  • Patients with advanced idiopathic knee OA and scheduled for unilateral total knee arthroplasty will be considered candidates for the present study and will be asked to participate
Exclusion Criteria:
  • if they had undergone another hip or knee joint replacement in the previous year

  • if they had any medical condition in which exercise was contraindicated

  • if they had any disease that affected functional performance

Contacts and Locations

Locations

No locations specified.

Sponsors and Collaborators

  • Gazi University
  • Gulhane Training and Research Hospital

Investigators

  • Study Director: Zeynep Hazar, Gazi University
  • Study Chair: Cemil Yıldız, Gulhane Training and Research Hospital
  • Principal Investigator: Sevim Beyza Ölmez, Gazi University
  • Principal Investigator: Beyza Yazgan, Gazi University
  • Principal Investigator: İnci Ayaş, Gazi University

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
Sevim Beyza Ölmez, Principal Investigator, PhD, Gazi University
ClinicalTrials.gov Identifier:
NCT05967637
Other Study ID Numbers:
  • 2023-874
First Posted:
Aug 1, 2023
Last Update Posted:
Aug 3, 2023
Last Verified:
Aug 1, 2023
Individual Participant Data (IPD) Sharing Statement:
No
Plan to Share IPD:
No
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No
Keywords provided by Sevim Beyza Ölmez, Principal Investigator, PhD, Gazi University
Additional relevant MeSH terms:

Study Results

No Results Posted as of Aug 3, 2023